-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617A.O3.6 617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Molecular Markers and Clinical Implication

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 4:30 PM-6:00 PM
W110, Level 1 (Orange County Convention Center)
Moderators:
Wolfgang Kern, MD, MLL Munich Leukemia Laboratory and R. Coleman Lindsley, MD, PhD, Dana-Farber Cancer Institute

Disclosures:
Kern: MLL Munich Leukemia Laboratory: Employment , Equity Ownership .
4:30 PM

Jessica Pollard, MD1,2, Todd A. Alonzo, PhD3,4, Robert B. Gerbing, MA4*, Susana C. Raimondi, PhD5, Betsy A. Hirsch, PhD6*, Lillian Sung, MD, PhD7, Richard Aplenc, MD, PhD8, Erin M. Guest, MD9, Irwin D. Bernstein, MD10,11, Michael R. Loken, PhD12*, Soheil Meshinchi, MD, PhD10,13 and Alan S. Gamis, MD, MPH14

1Maine Children's Cancer Program, Maine Medical Center, Scarborough, ME
2Department of Pediatrics, Tufts University, Boston, MA
3Keck School of Medicine, University of Southern California, Los Angeles, CA
4Children's Oncology Group, Monrovia, CA
5Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
6University of Minnesota, Minneapolis, MN
7Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
8Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
9Division of Hematology/Oncology, Children's Mercy Hospitals & Clinics, Kansas City, MO
10Department of Pediatrics, University of Washington, Seattle
11Fred Hutchinson Cancer Research Center, Seattle, WA
12Hematologics Inc., Seattle, WA
13Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
14Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

4:45 PM

Jessica Pollard, MD1,2, Todd A. Alonzo, PhD3,4, Robert B. Gerbing, MA4*, Yi-Cheng Wang, MS4*, Jason Joaquin5*, Susana C. Raimondi, PhD6, Betsy A. Hirsch, PhD7*, Lillian Sung, MD, PhD8, Richard Aplenc, MD, PhD9, Irwin D. Bernstein, MD5,10, Alan S. Gamis, MD, MPH11 and Soheil Meshinchi, MD, PhD10,12

1Maine Children's Cancer Program, Maine Medical Center, Scarborough, ME
2Department of Pediatrics, Tufts University, Boston, MA
3Keck School of Medicine, University of Southern California, Los Angeles, CA
4Children's Oncology Group, Monrovia, CA
5Fred Hutchinson Cancer Research Center, Seattle, WA
6Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
7University of Minnesota, Minneapolis, MN
8Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
9Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
10Department of Pediatrics, University of Washington, Seattle
11Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
12Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

5:00 PM

Annette Fasan, PhD1*, Claudia Haferlach, MD1, Karolína Perglerová2*, Sonja Schindela1*, Susanne Schnittger, PhD1, Wolfgang Kern, MD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

5:15 PM

Vincent-Philippe Lavallée, M.D.1,2, Patrick Gendron, M.Sc1*, Geneviève Boucher, M.Sc1*, Sébastien Lemieux, Ph.D.1*, Richard Neil Armstrong, Ph.D.1*, Isabel Boivin, M.Sc1*, Guy Sauvageau, M.D., Ph.D.1,2,3,4 and Josée Hébert, M.D.1,2,3,4

1The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
2Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
3Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada
4Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada

5:30 PM

Elli Papaemmanuil, PhD1*, Moritz Gerstung, PhD1*, Lars Bullinger, MD2, Verena I. Gaidzik, MD2*, Peter Paschka, MD2, Michael Heuser, M.D.3, Felicitas Thol, MD4, Niccolo Bolli, MD5, Arnold Ganser, M.D.4, Konstanze Dohner, MD6, Richard F. Schlenk, MD7, Hartmut Dohner, MD2 and Peter J Campbell, MD, PhD5*

1Wellcome Trust Sanger Institute, Cambridge, United Kingdom
2Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
3Hematology, Hemostasis, Oncology and SCT, Hannover Medical School, Hannover, Germany
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Cancer genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
6Department of Internal Medicine III,, University of Ulm, Ulm, Germany
7University Hospital of Ulm, Ulm, Germany

5:45 PM

Patricia Silva1*, Martin Neumann, MD1,2*, Sebastian Vosberg, MSc3,4,5*, Cornelia Schlee1*, Konstandina Isaakidis1*, Michael P Schroeder1*, Jutta Ortiz-Tánchez1*, Lars R. Fransecky1*, Teresa Hartung1*, Alexander Graf, PhD4*, Stefan Krebs, PhD4*, Helmut Blum, PhD4*, Gerhard Ehninger6,7, Hubert Serve, MD8,9, Wolfgang E Berdel, MD10, Philipp A. Greif11,12,13*, Christoph Röllig, MD6,14* and Claudia D Baldus, MD1,2

1Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
2German Cancer Consortium (DKTK), Berlin, Germany
3Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany
4Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
5German Cancer Consortium (DKTK), Heidelberg, Germany
6German Cancer Consortium (DKTK), Dresden, Germany
7Medical Clinic and Polyclinic I, University Hospital TU Dresden, Dresden, Germany
8German Cancer Consortium, Frankfurt, Germany
9Department for Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt am Main, Germany
10Department of Medicine A, University Hospital Münster, Muenster, Germany
11German Cancer Consortium (DKTK), Munich, Germany
12Department of Internal Medicine 3, Ludwig-Maximilians-University, Munich, Germany
13German Cancer Research Center (DKFZ), Heidelberg, Germany
14Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany

*signifies non-member of ASH